Mauricio Garcia Saenz de Sicilia

Associate Professor

University of Arkansas for Medical Sciences

faculty

Internal Med, College of Medicine

2 h-index 4 pubs 7 cited

Is this your profile? Verify and claim your profile

Biography and Research Information

OverviewAI-generated summary

Dr. Mauricio Garcia Saenz de Sicilia's research focuses on liver disease and transplantation. He has investigated factors influencing liver transplant referral and outcomes, including the impact of socioeconomic status on women awaiting transplant. His work also explores the prediction of esophageal varices in patients with advanced chronic liver disease and the intersection of non-alcoholic fatty liver disease (NAFLD) and drug-induced liver injury (DILI), characterizing them as a "metabolic storm."

Dr. Garcia Saenz de Sicilia received his medical degree from the University of National Autonomy of Mexico, where he also completed his internal medicine residency and gastroenterology fellowship. He furthered his training with an advanced fellowship in transplant hepatology at the University of Nebraska. He is board-certified in internal medicine and gastroenterology. His collaborators at the University of Arkansas for Medical Sciences include Martha Estrada, Martha M Estrada, Ragesh B. Thandassery, and Fares Mashal.

Research Overview

Dr. Mauricio Garcia joined the Division of Gastroenterology and Hepatology in the UAMS Department of Internal Medicine after completing an advanced fellowship in advanced transplant hepatology at the University of Nebraska. He received his medical degree from the University of National Autonomy of Mexico and completed his residency in internal medicine and a fellowship in gastroenterology from there as well. He is board certified in internal medicine and gastroenterology.

Metrics

  • h-index: 2
  • Publications: 4
  • Citations: 7

Selected Publications

  • Predicting Esophageal Varices and Varices Needing Treatment in Compensated Advanced Chronic Liver Disease (2025) DOI
  • Non-alcoholic fatty liver disease and drug induced liver injury: A metabolic storm waiting to happen (2025) DOI
  • Women Referred for Liver Transplant Are Less Likely to Be Transplanted Irrespective of Socioeconomic Status (2023) DOI

Grants & Funding

  • 205952 A Phase 2, Double-Blind, Randomized Study Evaluating the Safety, Tolerability, and Efficacy of GS-4997 in Combination with Prednisolone versus Prednisolone Alone in Subjects with Severe Alcoholic Hepatitis (AH) Gilead Sciences, Inc. Principal Investigator
  • No FP attached TARGET PharmaSolutions Inc Principal Investigator
  • 205952 A Phase 2, Double-Blind, Randomized Study Evaluating the Safety, Tolerability, and Efficacy of GS-4997 in Combination with Prednisolone versus Prednisolone Alone in Subjects with Severe Alcoholic Hepatitis (AH) Gilead Sciences, Inc. Principal Investigator

Collaborators

Researchers in the database who share publications

Similar Researchers

Based on overlapping research topics